Businesses, entrepreneurs, advocates, patients, investors, educators, and consumers, are invited to attend the NECANN Convention, a physical event being held in Albany, New York on August 26-27, 2022. NECANN has been producing popular and influential events to local communities throughout the northeast and beyond since 2014, shaping the developing cannabis economy by creating an important hub of resources and communication focused on local markets. NECANN events attract a huge number of hemp, MMJ, and cannabis industry professionals in the Northeast, and represent a home base for the New England cannabis industry. The New England Cannabis Convention offers a wonderful opportunity for the local community to grow and prosper. There are robust networking, communication, and business opportunities for cannabis cultivators, consumers, and business vendors across the region. The convention brings together the local cannabis community and fosters interactive trade and communication. New and established businesses, cannabis growers, and dealers, can discover business prospects and connect with top cannabis companies and investors. For budding entrepreneurs, it’s a wonderful forum that offers the opportunity to learn the latest industry trends in cannabis cultivation and trading. Touted as the key event for cannabis businesses on the East Coast, NECANN events are considered one of the best organized for the cannabis community, professionally run by a highly experienced team that devotes months of planning and research to put the event together. While these events offer phenomenal networking and informational opportunities, participants also enjoy numerous amenities in a fun environment. Cannabis experts throughout the region will share insights and their knowledge with a wide cannabis audience through vending, guest speaking, and interactive sessions at NECANN New York. The event is attended by industry stalwarts and thought leaders who will discuss business strategies and the future trends of this growing industry. They will also throw light on the latest products and technologies specifically oriented to the local cannabis community. Businesses looking to pitch their products and services should make contact as soon as possible through the link below. To learn more, please visit https://necann.com/new-york-convention/.

• The $70-billion global power inverter market is expected to climb to $95 billion by 2028
• Hillcrest has patented new inverter technology with an initial focus on the EV market that can make EVs lighter and more powerful with extended range
• The company has released an updated white paper on the benefits of the technology, which has quickly caught the attention of companies across multiple industries

It’s not uncommon for new technology to start out slow and then hit a hockey-stick type of growth. The reasoning is simple: it takes time to get the concept mainstream and then more companies jump in the mix, exponentially increasing the manpower and investment behind it. Take electric vehicles (“EVs”) for instance. A decade ago, there were only a handful of players. Now, some carmakers are transitioning to all electric and countries globally are under mandates to eliminate fossil-fuel-powered vehicles entirely in the coming decades. To that point, some of the technology of the future isn’t exactly far down the road. “Tomorrow is today,” as explained by Don Currie, CEO of Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), in a recent Bell2Bell podcast. Headquartered in Vancouver, British Columbia, Hillcrest is a clean technology company developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. Specifically, Hillcrest is in the commercialization phase of a high-efficiency inverter that is already of great interest across multiple industries, including the EV market, which is the company’s initial focus. Today’s EVs have four critical components: battery system, inverter, motor, and onboard charger. The inverter converts direct current (“DC”) into alternating current (“AC”) for use in the electric motors in the drivetrain, or propulsion system. The designs of today’s inverters are a careful balance of range and cost considerations, and, frankly, ripe for innovation to overcome challenges sapping system efficiency. This is Hillcrest’s sweet spot, as discussed in a recently updated white paper on the company’s technology. The update added the latest results from testing and built upon previously confirmed efficiency of the inverter by specifically looking at efficiencies related to Hillcrest’s mastery of zero voltage switching, or soft switching. According to Hillcrest CTO Ari Berger, the new test results, “…clearly demonstrate that zero-voltage switching is both feasible and it offers several cost and performance benefits relative to overall system size, complexity and weight of future electric vehicles.” Hillcrest’s inverter technology eliminates today’s design trade-offs, with inverter efficiency greater than 99%. While allowing high switching frequencies without the traditional sacrifices, Hillcrest’s inverter is smaller, lighter, and more powerful, a combination that improves system performance and reliability. Thermal management can be an engineer’s nightmare as EVs produce a great deal of heat. Another benefit of Hillcrest’s inverter technology is that it reduces thermal management requirements, further adding to safety and performance. These differentiating factors have generated quite a bit of interest from upstart companies through Tier 1 suppliers to global automakers. Lending some color as to why the surge in interest, Harald Hengstenberger, managing director and founder of Systematec GmbH, a strategic partner to Hillcrest and current power electronics design house to the German automotive industry, recently said, “The ability of the Hillcrest high-efficiency inverter to operate at much higher switching frequencies without generating additional losses will now allow motor manufacturers to take advantage of new motor concepts not previously available to them.” Hillcrest is currently in the commercial prototype phase for its EV traction inverter and expects to have working prototypes in hand in the coming months. At that point, interested parties will be invited to come see them firsthand operating in the lab, which could result in agreements from potential partners or customers before the end of year, opined Currie during the Bell2Bell podcast. With the global power inverter market currently at $70 billion and expected to climb to $95 billion by 2028, Hillcrest is positioned well to capitalize on the burgeoning EV market. For more information, visit the company’s website at www.HillcrestEnergy.tech. NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

• Fossil fuel-dependent households face up to 94% future cost increases
• GeoSolar’s patent pending SmartGreen(TM) system offers energy independence, eliminates CO2 emissions
• SmartGreen(TM) features solar panels, geothermal ground loops, applications include new developments and existing buildings in commercial and residential markets
• GeoSolar successfully installed in Colorado test market, company eyes 120 million-home U.S. market
• Company qualified by SEC to conduct Regulation A+ capital raise

Worldwide political conflict, energy supply shortages, and increased dependence on fossil fuels may lead to future cost increases of up to 94% for some households in the United States (https://ibn.fm/UBzYd). GeoSolar Technologies (“GST”), a Denver-based climate technology company, offers a way out with its SmartGreen(TM) residential and commercial energy systems, empowering Colorado residents and businesses with energy independence by harnessing the power of the sun and earth. Up to 84 million homes in the United States depend on obsolete fossil fuel-driven energy systems (https://ibn.fm/1ICkK). These homes are creating an unhealthy toxic living environment by contributing approximately 33% of total CO2 emissions in the United States, where 62% of the electricity used in buildings is generated from natural gas and coal-fired power plants. GeoSolar is dedicated to delivering a cleaner, safer indoor and outdoor living environment with SmartGreen(TM) – a complete renewable energy system that lowers utility bills, increases real estate values, helps humanity decrease dependence on fossil fuels, and contributes to a healthier planet. GeoSolar generates electricity requirements through solar panels and geothermal ground loops and disperses that energy to heat and cool the building, power appliances, and charge electric vehicles. Efficiency is improved by tightening the home’s building envelope, upgrading insulation, replacing windows, and installing LED lighting systems. The system can be built into new developments or retrofitted to existing homes within a few weeks, starting with an initial assessment that considers existing infrastructure to ensure optimal customization for any building size, type, or design. Energy requirements and usage are reviewed to develop the right-sized system, enabling property owners to reduce or eliminate utility bills and shave carbon emissions by up to 800 pounds per year (https://ibn.fm/rgdaw). GeoSolar’s patent-pending system is already achieving exceptional results with a successful track record of installations in multiple test buildings across Colorado. The company aims to apply GeoSolarPlus to 120 million homes, buildings, and businesses with the goal of decreasing carbon emissions by 60 trillion tons, reducing fossil fuel dependence, and improving health for residents and working people across the country. GeoSolar has been qualified by the U.S. Securities and Exchange Commission to conduct a Regulation A+ capital raise, allowing almost anyone to invest in the company’s technology for as little as $300 (https://ibn.fm/Appaw). For more information on GeoSolar’s Regulation A+ capital raise, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• Lexaria just completed dosing for its HYPER H21-4 human clinical study that dosed 64 patients aged between 40 and 70 with measured elevated blood pressure, stage 1 and stage 2 hypertension
• HYPER-H21-4, Lexaria’s most ambitious hypertension clinical study yet, builds on the success of HYPER-H21-1 and HYPER-H21-2, both completed in 2021
• It explores the use of the company’s patented DehydraTECH(TM) technology in the potential treatment of hypertension
• Lexaria is confident that the additional data sets collected over the course of the study will lead to supplementary applications for DehydraTECH while providing valuable additional insights into the long-term health benefits of this compound that might otherwise remain undetected

In November 2021, Lexaria Bioscience (NASDAQ: LEXX) announced its most ambitious hypertension study yet, HYPER-H21-4. The goal of the study, according to Lexaria’s Chief Executive Officer (“CEO”), Chris Bunka, was to “Support the company’s goals related to pursuit of regulatory approvals for DehydraTECH-CBD for potential use as a treatment for high blood pressure,” (https://ibn.fm/MKysj). At the close of the year, Lexaria received independent Review Board (“IRB”) approval ahead of schedule, which marked a significant milestone for the company. It would set the stage for the commencement of the study in the year 2022 while allowing Lexaria to explore the full potential of its patented DehydraTECH(TM) technology in hypertension treatment (https://ibn.fm/7DSdQ). On July 27, 2022, Lexaria announced that dosing with DehydraTECH-processed cannabidiol (“DehydraTECH-CBD”) had been completed in a multi-week human clinical hypertension study. Most notably, no serious adverse events were reported due to the dosing: the absence of serious adverse events is a critical goal of typical Phase I and Phase II FDA-registered studies Furthermore, the whole undertaking was completed on schedule, another huge milestone for the company as it works towards enhancing its understanding of DehydraTECH-CBD and its effectiveness in treating cardiovascular and other disease states beyond hypertension (https://ibn.fm/jCJFy). “We are extremely pleased that dosing has been completed on time in this multi-week clinical study without any serious adverse events having occurred,” noted Mr. Bunka. “Demonstrating a noteworthy safety and tolerability profile relative to conventional anti-hypertensive medications is one of Lexaria’s major goals with this program, and avoiding serious adverse events at clinically efficacious doses will be a primary requirement to achieve eventual regulatory marketing authorizations,” he added. This HYPER-H21-4 study consisted of male and female volunteers aged between 40 and 70. These volunteers had documented or measured elevated blood pressure, mild (stage 1) hypertension, to moderate (stage 2) hypertension. They received DehydraTECH-CBD every day for five weeks, with the doses escalating between 225 mg/day to 450 mg/day over the study duration, adjusted relative to body weight. The study’s extended duration allowed Lexaria to collect critical data monitoring the safety and efficacy of its DehydraTECH-CBD over time. This allowed the company to evaluate the potential for longer health benefits. Some of the study outcomes include vascular health, incorporating arterial stiffness and autonomic balance, electrocardiogram (“ECG”) analysis, brain structure and function through MRI testing, and blood biomarkers, among others. Lexaria is confident that each of these data sets will lead to additional applications for DehydraTECH-CBD while also providing valuable additional insights into the long-term health benefits of this compound that might otherwise remain undetected. Analysis of most of the data collected since the beginning of the study has begun and results should begin to be released in September 2022, with additional results to be release subsequently. HYPER-H21-4 builds on HYPER-H21-1 and HYPER-H21-2 studies, all conducted in 2021. Both of these previous studies evidenced a rapid and sustained drop in blood pressure with DehydraTECH-CBD in what Mr. Bunka described as “encouraging early results.”  As a result, Lexaria is optimistic that with the success of its latest study, its DehydraTECH-CBD will offer a better alternative to existing hypertension drugs in the market, mostly known for their unwanted side effects once approved. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The global online music streaming industry is expected to double in size over the next five years
• Friendable is leveraging this industry through its 360-degree artist platforms – Fan Pass Live, Artist Republik, and FeaturedX
• The Fan Pass Live artist platform offers independent artists full control over the production, distribution, and marketing of their music – including the resources necessary to collect revenue from it

The global online music streaming industry was valued at $12.83 billion in 2019 and is projected to reach $24.71 billion by 2027, growing at a CAGR of 9.8%, according to an Allied Market Research report (https://ibn.fm/4vHdY). The increase in penetration of 5G, artificial intelligence, and machine learning are all expected to impact this growth positively – including the high-speed data capabilities of 5G, which are 10 times faster than 4G. The Allied Market Research report also cites an increase in on-demand streaming, contributing to more than two-thirds of the market due to pandemic influence. To capitalize on this market’s expansion, Friendable (OTC: FDBL), a mobile technology and marketing company focused on developing and identifying products, services, and brand opportunities with mass-market potential and scalability, released its flagship offering, Fan Pass Live artist platform, in July 2020. Now, Friendable’s Fan Pass Live has become the 360-degree offering for independent artists, offering music production, distribution, and marketing with the acquisition of Artist Republik and FeaturedX in January 2022. The company has identified the gaps independent artists face in the industry and has developed the ultimate “anti-label” solution. Artists under label control feel a lack of support from these labels, including financial burdens by strict contracts and excessive fees. There is also a lack of access to resources that allow artists to independently manage their careers in one place. On average, artists lose 90% of streaming revenue to record labels, 10% to booking agents, and 15 to 20% of their overall income to managers. Fan Pass Live’s platform of artist services provides independent music artists with a 360-degree solution that removes gatekeepers, middlemen, and 100% control of their music remains with them. The platform offers everything an artist needs to produce, distribute, and market their music while collecting the maximum amount of revenue. Music artists using Fan Pass Live benefit from:

• Music Distribution and Management
• Music Production Assistance
• Press Release and Instagram Promotion
• Digital Storefront Activation
• Artist Marketplace for Collaborations
• Merch, Logo, and Promotional Design Support
• Virtual Concert Booking and Ticketing Mobile Streaming Service
• Live Streaming Support
• Revenue From Fan Tips, Monthly Artist Contests, Merch, and Ticket Sales
• Access to Fan Data and Performance Analytics
• Monthly Artist Contests
• NFT Development and Metaverse Performances – Coming Soon

Additionally, the acquisition of FeaturedX offers independent artists the opportunity to collaborate with other artists, find musical compositions, and more. The addition of FeaturedX makes it easy for artists to book an artist feature, collaborate, and download the completed track for distribution through Artist Republik. Since the acquisition, the company has seen exponential growth in metrics across the board – user engagement, artist engagement, and more. The company’s current contest for its artist members is The Song of Summer Contest from Artist Republik and is already underway. Registration closed on August 8th, and the top five artists across five genres battle it out to win a total of $5,000 in rewards ($1,000 per genre). On September 1st, the top 10 songs will battle it out to be named the winner in their respective genre and take home the grand prize in each category. Artists get to keep everything they earn from the contest – furthering Friendable’s mission to support the work of independent music artists globally. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Physical casino visits never recovered from COVID-19 restrictions
• Online gambling industry growing rapidly at CAGR of 11.7 percent from 2022 to 2030, expected to reach $153.6 billion by 2030
• Esports, social gaming, online poker tournaments, relaxed legislation driving user growth
• GMGI offers B2B partners access to 10,000+ games from over 25 leading game providers, aims to launch Esports betting platform

Recent technological advances have made online gambling easier, more convenient, and more enjoyable for some users when compared to a physical casino experience. Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, continues to leverage technological advances and incorporate them into its turnkey B2B solutions for online gambling operators. GMGI appears to be on trend with the movement of users online, and away from physical gambling which has not recovered from COVID-19 business restrictions. According to a recent report by the Las Vegas Convention and Visitors Authority, visitor numbers grew by roughly 69.4 percent between 2020 and 2021, however are still down 24.2 percent when compared to 2019 (https://ibn.fm/rLen1). Several factors aside from COVID-19 shutdowns drove the trend, including the release of new iGaming offerings, increased sports betting, online poker tournament participation, mobile device proliferation, and widespread legalization throughout the world. Grand View Research expects the trend to continue at a CAGR of 11.7 percent from 2022 to 2030 (https://ibn.fm/W4rFo). Analysts at the consulting and research firm pegged the industry at $65.53 billion in 2022 and expect revenues to reach $153.6 billion by 2030. Legalization of gambling in countries such as Germany, Italy, France, Spain, and Malta led to Europe’s 41 percent market dominance in 2021, however Asian countries such as Japan are rapidly taking market share as regulations relax throughout the world. Besides emerging technological trends, the industry is maturing to offer an exciting experience unique to the online world, exemplified by the growth of Esports. Organized Esports competitions featuring professional players give audiences the thrill of live video game action while offering gamblers opportunities to bet on outcomes via secure platforms. Along with Esports, other offerings like social gaming are emerging, offering users opportunities to play online, win prizes, gain points, and earn virtual currency. Golden Matrix leads the industry in providing turnkey B2B iGaming and Esports solutions for operators looking to enter the sector. Easily customized and highly modular, the company’s solutions are compatible with all major browsers, operating systems, and devices. In addition to offering B2B partners access to 10,000+ games from over 25 leading game providers, CEO Brian Goodman recently revealed the company’s plans to launch an Esports platform on Benzinga’s Esports Listmakers Series (https://ibn.fm/6WEbP). Based in Las Vegas, Nevada, Golden Matrix develops and owns online gaming intellectual property that includes configurable, modular, and scalable white-label B2B gaming platforms used by 600+ unique global casino operations. With critical IP that includes AI-optimized tools to retain and monetize users, GMGI is positioned to lead the industry in offering profit-maximizing solutions for its B2B partners. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

• Odyssey Health Inc. is a medical product developer advancing treatments for conditions ranging from choking to neurodegenerative maladies
• The company’s flagship candidate is a drug-device combination for treating mild brain injuries (“MTBIs”) known as PRV-002, which is currently being used in clinical testing with human volunteers
• Odyssey Health recently announced a redesign of its website and an update of its corporate presentation to better communicate its efforts and allow interested investors to access information regarding the company
• The website redesign follows on the company’s name change earlier this year to similarly improve the expression of its brand identity

Medical technology product developer Odyssey Health (OTC: ODYY) is advancing testing for a proprietary drug and device combination designed to deliver a novel solution for people experiencing a concussive brain injury, and the company recently introduced a redesigned website to help it better communicate its progress. Odyssey Health has completed preclinical animal testing on its fully synthetic neurosteroid known currently as PRV-002 and is now beginning work with human clinical volunteers. In the animal testing, PRV-002 demonstrated the ability to alleviate symptoms related to concussions such as memory impairment, anxiety and motor/sensory difficulties. The redesign of the company website follows on Odyssey’s name change earlier this year to emphasize Odyssey’s brand focus on the health therapy industry and its mission to “create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions,” including PRV-002 and products to remove a throat obstruction in a choking person, to establish a standard of early detection for heart disease, and to treat the neuro-degenerative Niemann-Pick disease. “The launch of our new website is an important next step in the ongoing evolution of Odyssey and will enable us to provide more transparent communications with our shareholders and other stakeholders,” CEO Michael Redmond stated Aug. 4 (https://ibn.fm/ATWbK). The website’s address is www.OdysseyHealthInc.com. In addition, the company has updated its corporate presentation to better express the need for a concussive brain injury treatment as well as Odyssey’s efforts to lead the way. The new presentation can be found at https://ibn.fm/TooCZ. The federal government’s Centers for Disease Control and Prevention (“CDC”) estimates that about 1.5 million people in the United States experience traumatic brain injuries (“TBIs”) each year (https://ibn.fm/Wb08R). The agency’s most recent data indicates that of these TBIs, about 223,135 were serious enough in 2019 to lead to hospitalizations and 64,362 resulted in death — effectively 611-plus TBI-related hospitalizations per day and 176 TBI-related deaths per day (https://ibn.fm/5ih3M). The CDC reports that a large number of TBI deaths result from suicides, but the incidence of TBI-related injuries in child athletes, in particular, has drawn national attention to concerns about the long-term effects of head injuries and efforts to prevent or respond to them. Professional athletes, military personnel and elderly fall victims have also been recognized as a large segment of society that could benefit from effective treatment of concussion head injuries. Currently, the standard of care for concussions is rest, pain-relief medicine and anti-depressants. Such TBIs are generally initially reported as mild injuries (“MTBIs”) because of their minimal degree of impairment for normal activities, but the CDC’s reports note that long-term effects such as memory impairment have resulted in an estimated 5.3 million Americans living with a permanent TBI-related disability. Repeat concussions can lead to early dementia and a condition known as Chronic Traumatic Encephalopathy (“CTE”), but at the time no drug treatment for such injuries has been approved by the U.S. Food and Drug Administration (“FDA”). Odyssey Health’s product is an intranasal device that delivers the proprietary neurosteroid into the upper nasal cavity (but not into the esophagus or lungs), where it can be taken up into the brain, across the blood-brain barrier, to minimize the results of the injury. The company intends to build on its flagship product with eventual therapies for other brain injury and neuropsychiatric disorders ranging from serious depression to amyotrophic lateral sclerosis (known as ALS, or Lou Gehrig’s disease). In addition to its website, Odyssey provides updates on its activities through social media channels, such as Twitter (https://twitter.com/OdysseyHealth1), Facebook (https://www.facebook.com/odysseyhealthinc) and LinkedIn (www.linkedin.com/company/odysseyhealthinc/). YouTube: (https://www.youtube.com/channel/UCsS–v0od_fYIBu2tvqmj9Q ) For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Vertical farming projected to reach more than $25 billion by 2030, with a CAGR of 23.3%
• MRFR report notes that “vertical farming systems and technologies offer a superior approach to farming methods”
• ACTX GrowPods are essentially vertical micro-farms that can be placed anywhere, allow cultivation of a wide variety of crops, 365 days a year

A recent Market Research Future (“MRFR”) report shows that vertical farming is projected to reach more than $25 billion by 2030, with a CAGR of 23.3% (https://ibn.fm/BSsCd). Those numbers bode well for Advanced Container Technologies (OTC: ACTX), a company in the business of selling GrowPods, self-contained, automated, indoor “micro-farms” that are building a reputation in the vertical farming space. “Vertical farming systems and technologies offer a superior approach to farming methods, allowing for the growing of large amounts of crops inside a confined land area while requiring little financial investment and having no negative impact on the environment,” reported MRFR’s comprehensive research report. “The main reason for this is because perpendicular stack-based farming lowers the need for additional land and allows for full land utilization for farming, with optimal land and energy use yielding significant returns. The vertical farming market has seen diversified growth in all segments and across different regions as a result of rising populations and rising per capita incomes, which has shifted people’s demands toward more organic, health, and environment-friendly foodstuffs, resulting in the development of the vertical farming market.” The report also noted that consumers are more aware of what they are eating and are prioritizing health. These changes have “fueled the market for organic farming, which produces fruits and vegetables that are free of insecticides and pesticides and high in nutritional content,” the report continued. “The desire for organic and high-quality foods has transformed vertical farming firms’ production capabilities and created a foundation for ensuring high-quality and quantity-approved production to fulfill rising needs. In addition, people have begun to cultivate fruits and vegetables indoors, giving rise to the concept of indoor vertical farming.” Advanced Container Technologies is keenly aware of the opportunities in vertical farming and appears uniquely suited for growth in the space. The company is the sole distributor of GrowPods, which are advanced, self-contained hydroponic containers manufactured by GP Solutions Inc. “These innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year,” states the company. “Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.” In addition to selling and distributing GrowPods, Advanced Container Technologies offers related equipment and supplies. Additionally, the company designs and sells patented, proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com. NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://ibn.fm/ACTX

One of the top summits in the investor space, the Q3 Investor Summit will be held on August 16-17, 2022, as a virtual event. The Q3 Investor Summit offers phenomenal opportunities for mid-cap and small-cap companies to connect with potential investors. Investors looking for novel investment opportunities can discover innovative ideas and a new arena of investment scope at the conference. Dynamic mid and small-cap companies will be at the Q3 event to present themselves, and many seasoned and well-qualified investors who have an intention to buy in the open market will be there. The high-quality audience participates in meaningful conversations and opens avenues for splendid investment opportunities. The webinar has an impressive lineup of speakers sharing their insights on investment opportunities, and presenting companies will leverage this opportunity to introduce their business through engaging presentations in front of an interactive and learned audience. Attendees can participate in the discussion panels where they will learn and gain valuable strategies given by industry influencers. The 30-minute webcast with Q&A (average is 40+ attendees), will be promoted on the conference website for 90 days post-conference. In addition, all participants have access to the 600 registered attendees. For enthusiasts who want to learn, personalized tech training sessions are also available. The Q3 Investor Summit features live presentations, one-to-one meetings, roundtables, workshops, discussions, and keynotes from veteran industry leaders and experienced executives with networking opportunities all across the globe. The summit is conducted in a safe and conducive virtual environment where the participants’ privacy is secure and protected. The Q3 Investor Summit is a well-curated show put together for the investor community for connecting and networking in a friendly yet professional environment. The event attracts industries, businesses, entrepreneurs, and institutions from the healthcare, consumer, financial, technology, cannabis, blockchain, and industrial sectors looking for investment and networking opportunities. Startups and small companies can connect with industry veterans and peers at this forum to expand their business scope. The Investor Summit has substantial media coverage, a boon for the small and mid-cap operations seeking to gain visibility in the competitive business world. The Q3 Investor Summit is the perfect platform to connect with high-level, retail and institutional investors. To learn more, please visit https://investorsummitgroup.com/.

• Correlate Infrastructure Partners is a technology-enabled energy-optimization and clean-energy-solutions provider
• The company is set to benefit from the Inflation Reduction Act, which seeks to, among other things, reduce carbon emissions
• According to Correlate CEO Todd Michaels, the Inflation Reduction Act could potentially accelerate the company’s growth, support its ability to own and operate nationwide solar and storage assets, and contribute to strengthening the economy through clean energy project deployment

Last fall, the US Congress passed the Bipartisan Infrastructure Deal, boosting the Administration’s efforts to combat the climate crisis. The deal sought to modernize infrastructure and make infrastructure safer, thereby building resilience against extreme weather and climate change. It also looked to reduce greenhouse emissions by modernizing the nation’s passenger rail system, building out a national network of EV chargers, and delivering thousands of electric school buses nationwide (https://ibn.fm/wNhvv). In the latest developments that are expected to boost the efforts of companies like Correlate Infrastructure Partners (OTCQB: CIPI), the US Senate on August 7 passed the Inflation Reduction Act of 2022 (https://ibn.fm/vMcOh). The House of Representatives will likely pass the legislation within the following week. The legislation, among other things, is designed to grow domestic energy production and manufacturing in ways aimed to reduce carbon emissions by approximately 40% by 2030. The move comes in the wake of recent devastating events that include the worst flooding in the history of Kentucky, which dislodged houses and left scores dead, and record high temperatures from heatwaves affecting vast parts of South Central U.S. “The floods in Kentucky and extreme weather all around the country are yet another reminder of the intensifying and accelerating impacts of climate change and the urgent need to invest in making our communities resilient to it,” a recent article in The Guardian quotes the White House press secretary Karine Jean-Pierre as saying (https://ibn.fm/e6JKy). The recent Inflation Reduction Act and the November Bipartisan Infrastructure Deal capture these climate-oriented investments. As envisioned by the Inflation Reduction Act, the government is set to allocate $370 billion to climate change. The amount will go toward providing tax credits that spur the manufacturing of renewable energy and carbon-reducing solutions such as solar panels, wind turbines, and electric vehicle (“EV”) technologies. Specifically, the legislation extends the current Investment Tax Credit (“ITC”) another ten years and increases the credit for solar energy from 26% to 30% for projects completed in 2022. So far, the ITC has been credited with expanding the U.S. solar sector by over 10,000% since it was first implemented in 2006, according to the Solar Energy Industries Association (“SEIA”) (https://ibn.fm/DOOPS). The tax, production, and investment credits are also set to boost EV purchases. The federal investment will also fund research and state programs and includes money for preserving forests and coastal habitats as well as reducing pollution. In a news release that comments on this historic bill, Correlate Infrastructure Partners, an energy optimization and clean energy solutions provider, extols the legislation as “incredibly important for the collective industry in many ways” (https://ibn.fm/0qvLc). According to the company, the tax, investment, and production credits will empower renewable infrastructure companies like Correlate to provide property owners with a simplified route to optimizing their energy profile to renewables while reducing their carbon footprint. The increase and extension of the ITC, CEO Todd Michaels notes, will provide a more flexible structure for companies like Correlate to monetize that tax credit. “These two key proposals have the potential to accelerate Correlate’s growth, support our ability to own and operate nationwide solar and storage assets, and contribute to strengthening the economy through clean energy project deployment,” he adds. Backed by technology, Correlate offers a complete suite of proprietary clean energy assessment solutions that enable commercial real estate owners to optimize their buildings. In addition, the company develops and finances renewable energy projects that make investment properties more efficient. And with investors increasingly analyzing their existing and potential investments through the lens of ESG (Environmental, Social, and Governance), Correlate offers affordable and potentially profitable energy solutions that align with investors’ renewed outlook. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• The company’s platform Generates New Rent and Operating Income, Allowing You to Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI